Log in

Relevant bibliographies by topics / Mescalina / Journal articles

To see the other types of publications on this topic, follow the link: Mescalina.

Journal articles on the topic 'Mescalina'

Author: Grafiati

Published: 4 June 2021

Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Mescalina.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Jerí, F. Raúl, Carlos Carbajal, and César Sánchez M. "Efectos nocivos de fármacos simpaticomiméticos en un grupo de adolescentes." Anales de la Facultad de Medicina 54, no. 2 (2014): 75. http://dx.doi.org/10.15381/anales.v54i2.5021.

Full text

Abstract:

Se presentan 35 observaciones clínicas de jóvenes que usaron drogas alucinógenas durante dos a cuatro años en su mayoría. La proporción de varones era el triple en comparación con las mujeres, casi todos procedían de hogares bien integrados y pertenecían a un nivel socio-económico alto o mediano. Las drogas empleadas fueron marihuana, LSD, barbitúricos, mescalina, afetamina, metaqualona y alcohol, en diversas combinaciones. La totalidad de estos jóvenes presentaron signos de perturbaciones psicológicas, generalmente disturbios de la personalidad, antes de iniciarse en el uso de alucinógenos. En esta serie se ha comprobado que los fármacos simpaticomiméticos (marihuana, LSD, mescalina y anfetamina) pueden desencadenar graves cuadros psicóticos agudos, sub-agudos y crónicos. Es necesario que las autoridades de Salud establezcan programas integrales de prevención y tratamiento de las adicciones en la juventud, para controlar la pandemia que actualmente extiéndese por las principales ciudades del Perú.

APA, Harvard, Vancouver, ISO, and other styles

2

Baldera-Aguayo, Pedro A., and Víctor M. Reyna Pinedo. "ESTUDIO FITOQUÍMICO DE Echinopsis peruviana." Revista de la Sociedad Química del Perú 80, no. 3 (2014): 202–10. http://dx.doi.org/10.37761/rsqp.v80i3.229.

Full text

Abstract:

El cactus “San Pedro Macho” (Echinopsis peruviana o también conocido como Trichocereus peruviana) debe en parte su nombre y su importancia a su similaridad, tanto taxonómica como en su contenido de alcaloides, con el muy conocido cactus “San Pedro Hembra” (Echinopsis pachanoi) o comúnmente denominado “San Pedro”, el cual es la especie más importante entre las plantas empleadas en Medicina Tradicional (MT) en el norte del Perú. Este trabajo fitoquímico de la especie Echinopsis peruviana cultivada en Perú comprende el análisis cualitativo de sus metabolitos secundarios, la cuantificación total de alcaloides y el aislamiento del alcaloide mescalina como su sal, el sulfato dihidratado, a partir de la corteza de los tallos del cactus E. peruviana. Las técnicas ESI-MS; RMN 1H, 13C; IR; UV; análisis porcentual de elementos y Cromatografía en Capa Fina (CCF) fueron empleadas para caracterizar al compuesto aislado.

APA, Harvard, Vancouver, ISO, and other styles

3

Assunção, Teodoro Rennó. "Lotófagos (Odisseia IX, 82-104): comida floral fácil e risco de desistência." Classica - Revista Brasileira de Estudos Clássicos 29, no. 1 (2017): 273. http://dx.doi.org/10.24277/classica.v29i1.416.

Full text

Abstract:

Este artigo propõe uma tradução e um comentário do episódio dos Lotófagos na Odisseia (IX, 82-104), atentando tanto para sua organização interna enquanto episódio de viagem com uma cena típica de hospitalidade (resumida apenas à oferta de comida), quanto para sua posição e especificidade no conjunto das viagens maravilhosas de Odisseu (cantos IX a XII) e no conjunto da Odisseia. Ele tenta definir os significados possíveis de lōtós (“lótus”), tais como apresentados por Heródoto e Teofrasto, em confronto com os poucos dados presentes na Odisseia (convergindo em ser ele uma planta não cultivada e colhida), e – o que é mais importante – tenta definir também os efeitos do consumo do lótus, que são como os de uma droga perigosa (como o haxixe, o ópio ou a mescalina) que suprime a vontade de agir, ameaçando retrospectivamente o retorno de Odisseu e a própria narrativa da Odisseia.

APA, Harvard, Vancouver, ISO, and other styles

4

Carod Artal, Francisco Javier, and Carolina Benigna Vázquez Cabrera. "Mescalina y ritual del cactus de san Pedro: evidencias arqueológicas y etnográficas en el norte de Perú." Revista de Neurología 42, no. 08 (2006): 489. http://dx.doi.org/10.33588/rn.4208.2006040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jerí, Raúl, José Sánchez, and Alejandro Arellano. "Ensayo con el azacyclonol en algunas reacciones psicóticas agudas." Anales de la Facultad de Medicina 40, no. 1 (2014): 65. http://dx.doi.org/10.15381/anales.v40i1.10724.

Full text

Abstract:

Se presentan en esta comunicación los primeros resultados de un ensayo con el azacyclonol en algunas reaccionas psicóticas agudas. El azacyclonol es una de las drogas más recientes para el tratamiento de las psicosis. Tiene acción sobre el sistema nervioso central, inhibiendo probablemente la serotonina y por tanto produce efectos similares a la reserpina y a la clorpromazina. La actividad fundamental consiste en que anula las alteraciones clínicas y bio-eléctricas producidas por las drogas alucinóqenos (ácido lisérgico y mescalina). En diversas psicosis tóxicas y en reacciones esquizofrénicas agudas ha hecho desaparecer los trastornos mentales, algunas veces, en un tiempo extremadamente corto. Ciertas reacciones psicóticas han remitido durante la primero inyección endovenoso del preparado. En este trabajo, el primero que se hace en el país, se usó azacyclonol por vía endovenosa y oral en 11 casos, 5 sufrían de esquizofrenia paranoide, 3 de psicosis paranoide, 2 de psicosis tóxicas y 1 de una reacción obsesiva en la involución. Todos los casos eran recientes, con excepción de uno. El tiempo de observación ha variado entre 3-40 días, la dosis promedio fue de 100 mgs. diarios y los resultados han sido buenos en 1, regulares en 3 y nulos en 7 casos. Sin embargo, la serie es demasiado pequeña y el tiempo de observación muy breve para establecer conclusiones. El azacyclonol no produjo cambios electro-encefalográficos en cuatro pacientes estudiados, empleando electrodos corticales y basales, en los que se hizo la investigación antes y hasta dos horas después de la inyección endovenosa de 100-200 mgs.

APA, Harvard, Vancouver, ISO, and other styles

6

Halberstadt, Adam L., Muhammad Chatha, Stephen J. Chapman, and Simon D. Brandt. "Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice." Journal of Psychopharmacology 33, no. 3 (2019): 406–14. http://dx.doi.org/10.1177/0269881119826610.

Full text

Abstract:

Background: In recent years, there has been increasing scientific interest in the effects and pharmacology of serotonergic hallucinogens. While a large amount of experimental work has been conducted to characterize the behavioral response to hallucinogens in rodents, there has been little systematic investigation of mescaline and its analogs. The hallucinogenic potency of mescaline is increased by α-methylation and by homologation of the 4-methoxy group but it not clear whether these structural modifications have similar effects on the activity of mescaline in rodent models. Methods: In the present study, the head twitch response (HTR), a 5-HT2A receptor-mediated behavior induced by serotonergic hallucinogens, was used to assess the effects of mescaline and several analogs in C57BL/6J mice. HTR experiments were conducted with mescaline, escaline (4-ethoxy-3,5-dimethoxyphenylethylamine) and proscaline (3,5-dimethoxy-4-propoxyphenylethylamine), their α-methyl homologs TMA (3,4,5-trimethoxyamphetamine), 3C-E (4-ethoxy-3,5-dimethoxyamphetamine) and 3C-P (3,5-dimethoxy-4-propoxyamphetamine), and the 2,4,5-substituted regioisomers TMA-2 (2,4,5-trimethoxyamphetamine), MEM (4-ethoxy-2,5-dimethoxyamphetamine) and MPM (2,5-dimethoxy-4-propoxyamphetamine). Results: TMA induced the HTR and was twice as potent as mescaline. For both mescaline and TMA, replacing the 4-methoxy substituent with an ethoxy or propoxy group increased potency in the HTR assay. By contrast, although TMA-2 also induced the HTR with twice the potency of mescaline, potency was not altered by homologation of the 4-alkoxy group in TMA-2. Conclusions: The potency relationships for these compounds in mice closely parallel the human hallucinogenic data. These findings are consistent with evidence that 2,4,5- and 3,4,5-substituted phenylalkylamine hallucinogens exhibit distinct structure-activity relationships. These results provide additional evidence that the HTR assay can be used to investigate the structure-activity relationships of serotonergic hallucinogens.

APA, Harvard, Vancouver, ISO, and other styles

7

LeBlanc, Robert, Sohan De Silva, and Martin Terry. "Analysis of over-the-counter analgesics purported to contain mescaline from the peyote cactus (Lophophora williamsii: Cactaceae)." Journal of the Botanical Research Institute of Texas 15, no. 1 (2021): 125–37. http://dx.doi.org/10.17348/jbrit.v15.i1.1055.

Full text

Abstract:

The purpose of this study was to investigate samples of commercial over-the-counter products purported to contain extracts from peyote cactus (Lophophora williamsii), a vulnerable species. Samples were extracted with organic solvent and then washed to remove impurities. The extracts of these products were subjected to an analysis by real-time mass spectrometry (DART-MS) to determine the presence or absence of the alkaloid mescaline (3,4,5-trimethoxyphenethylamine). High-performance liquid chromatography (HPLC) was used to determine mescaline concentrations in the samples and to provide quantitative evidence of the concentration—if any—of mescaline in the products. If a detectable level of mescaline—a stable and abundant alkaloid of L. williamsii—was found in a given extract, then it was inferred that L. williamsii was present in the corresponding topical product. The results of this investigation show that most consumers who purchase the products in question are being defrauded if they believe they are buying L. williamsii-based medicines. The lack of mescaline—implying the lack of peyote—in these products suggests that wild populations of the vulnerable cactus L. williamsii, though currently being decimated on a massive scale in Mexico and the U.S. for other purposes, are rarely harvested for use in topical analgesic products. This conclusion is based on the finding that less than 5% of the ostensible L. williamsii-containing topical analgesic products that were analyzed in this study actually contained mescaline.

APA, Harvard, Vancouver, ISO, and other styles

8

Newbold, Richard, Sohan De Silva, and Martin Terry. "Correlation of mescaline concentrations in Lophophora williamsii (Cactaceae) with rib numbers and diameter of crown (U.S.A.)." Journal of the Botanical Research Institute of Texas 14, no. 1 (2020): 103–20. http://dx.doi.org/10.17348/jbrit.v14.i1.901.

Full text

Abstract:

Lophophora williamsii, peyote, is a small cactus growing to approximately 10 cm in diameter with a flat to dome-shaped spineless crown with fissures or ribs that develop following the Fibonacci series and whose numbers indicate relative degree of maturing. In this study crown tissue of 30 wild-collected specimens was analyzed to determine whether there was a correlation between the concentration of the primary alkaloid mescaline in crown tissue with the average diameter of the crown. We also compared mescaline concentration in three groups of ten individuals: 5 ribs (juvenile stage), 8 ribs (intermediate), and 13 ribs (elder/mature stage), since these Fibonacci numbers are the most stable and long-lasting on L. williamsii. This was designed to test the hypothesis that there is a positive correlation between mescaline concentration and both diameter and rib number. Nine greenhouse-grown specimens were likewise analyzed to serve as a control group for the study. All 39 tissue samples were subjected to an alkaloid extraction procedure followed by an acid-base washing procedure. Mescaline was identified using liquid-chromatography and mass spectroscopy and then quantified using reverse-phase high-pressure liquid chromatography. The Pearson’s Chi-squared test showed no statistical correlation between increasing mescaline concentration and increasing rib numbers for field-collected samples and greenhouse?raised control samples. Field-collected samples: P-value of 0.392; greenhouse control samples: P-value of 0.313. Similarly, field and greenhouse samples showed no statistical correlation between mescaline concentration and average diameter of the crown. Field-collected samples: P-value of 0.251; greenhouse control samples: P-value of 0.229. This study contributes to the understanding of this vulnerable species and to approaches to its overall conservation and the preservation of Native American culture.

APA, Harvard, Vancouver, ISO, and other styles

9

Kovacic, Peter, and Ratnasamy Somanathan. "Novel, Unifying Mechanism for Mescaline in The Central Nervous System: Electrochemistry, Catechol Redox Metabolite, Receptor, Cell Signaling and Structure Activity Relationships." Oxidative Medicine and Cellular Longevity 2, no. 4 (2009): 181–90. http://dx.doi.org/10.4161/oxim.2.4.9380.

Full text

Abstract:

A unifying mechanism for abused drugs has been proposed previously from the standpoint of electron transfer. Mescaline can be accommodated within the theoretical framework based on redox cycling by the catechol metabolite with its quinone counterpart. Electron transfer may play a role in electrical effects involving the nervous system in the brain. This approach is in accord with structure activity relationships involving mescaline, abused drugs, catecholamines and etoposide. Inefficient demethylation is in keeping with the various drug properties, such as requirement for high dosage and slow acting.There is a discussion of receptor binding, electrical effects, cell signaling and other modes of action. Mescaline is a nonselective, seretonin receptor agonist. 5-HTP receptors are involved in the stimulus properties. Research addresses the aspect of stereochemical requirements. Receptor binding may involve the proposed quinone metabolite and/or the amino sidechain via protonation. Electroencephalographic studies were performed on the effects of mescaline on men. Spikes are elicited by stimulation of a cortical area. The potentials likely originate in nonsynaptic dendritic membranes. Receptor-mediated signaling pathways were examined which affect mescaline behavior. The hallucinogen belongs to the class of 2AR agonists which regulate pathways in cortical neurons. The research identifies neural and signaling mechanisms responsible for the biological effects. Recently, another hallucinogen, psilocybin, has been included within the unifying mechanistic framework. This mushroom constituent is hydrolyzed to the phenol psilocin, also active, which is subsequently oxidized to an ET o-quinone or iminoquinone.

APA, Harvard, Vancouver, ISO, and other styles

10

Dinis-Oliveira, Ricardo Jorge, Carolina Lança Pereira, and Diana Dias da Silva. "Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions." Current Molecular Pharmacology 12, no. 3 (2019): 184–94. http://dx.doi.org/10.2174/1874467211666181010154139.

Full text

Abstract:

Background: Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cactus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood. Objective: This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro metabolic profile of the drug and its implications for the variability of response. Methods: Mescaline pharmacokinetic and pharmacodynamic aspects were searched in books and in PubMed (U.S. National Library of Medicine) without a limiting period. Biological effects of other compounds found in peyote were also reviewed. Results: Although its illicit administration is less common, in comparison with cocaine and Cannabis, it has been extensively described in adolescents and young adults, and licit consumption often occurs in religious and therapeutic rituals practiced by the Native American Church. Its pharmacodynamic mechanisms of action are primarily attributed to the interaction with the serotonergic 5-HT2A-C receptors, and therefore clinical effects are similar to those elicited by other psychoactive substances, such as lysergic acid diethylamide (LSD) and psilocybin, which include euphoria, hallucinations, depersonalization and psychoses. Moreover, as a phenethylamine derivative, signs and symptoms are consistent with a sympathomimetic effect. Mescaline is mainly metabolized into trimethoxyphenylacetic acid by oxidative deamination but several minor metabolites with possible clinical and forensic repercussions have also been reported. Conclusion: Most reports concerning mescaline were presented in a complete absence of exposure confirmation, since toxicological analysis is not widely available. Addiction and dependence are practically absent and it is clear that most intoxications appear to be mild and are unlikely to produce lifethreatening symptoms, which favors the contemporary interest in the therapeutic potential of the drugs of the class.

APA, Harvard, Vancouver, ISO, and other styles

11

Koupilová, Marie, Josef Herink, and Otakar Krs. "Influencing of Spatial Memory in Rats by DSP-4 and Mescaline." Acta Medica (Hradec Kralove, Czech Republic) 42, no. 2 (1999): 69–72. http://dx.doi.org/10.14712/18059694.2019.145.

Full text

Abstract:

Behavioural effects of two experimental neurotoxins, mescaline and DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine), on retention of spatial orientation were studied in the T - maze. The stereotaxic administration of both neurotoxins into the selected brain structures was chosen to reveal this effect. The intensity and time course of the neurotoxic effect were dependent on the brain area administered. Nevertheless, the lengthening of the latencies in reaching the goal was generally more marked after mescaline in comparison with DSP-4.

APA, Harvard, Vancouver, ISO, and other styles

12

Curtis-Haynes, Carole. "Sartre and the Drug Connection." Philosophy 70, no. 271 (1995): 87–106. http://dx.doi.org/10.1017/s0031819100042108.

Full text

Abstract:

Sartre's experimentation in February 1935 with the drug mescalin has been well documented by Simone de Beauvoir in her book The Prime of Life.1 She recalls that Sartre experienced under the influence of the drug not exactly hallucinations, ‘but the objects he looked at changed their appearance in the most horrifying manner:’ [POL 209]. The residual effects of this nightmarish experience left Sartre, not only for several days ‘in a state of deep depression’ [POL 210], but also produced moods that ‘recalled those that had been induced by mescalin.’

APA, Harvard, Vancouver, ISO, and other styles

13

Reynolds, Philip C., and Ervin J. Jindrich. "A Mescaline Associated Fatality." Journal of Analytical Toxicology 9, no. 4 (1985): 183–84. http://dx.doi.org/10.1093/jat/9.4.183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Jay, Mike. "100 years of mescaline." Monatshefte für Chemie - Chemical Monthly 150, no. 5 (2019): 957–59. http://dx.doi.org/10.1007/s00706-019-02425-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Bruhn, Jan G., Peter AGM De Smet, Hesham R. El-Seedi, and Olof Beck. "Mescaline use for 5700 years." Lancet 359, no. 9320 (2002): 1866. http://dx.doi.org/10.1016/s0140-6736(02)08701-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Fucci, N., and M. Chiarotti. "Mescaline in multi-coloured statuettes." Forensic Science International 82, no. 2 (1996): 165–69. http://dx.doi.org/10.1016/0379-0738(96)01987-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Kintz, Pascal. "Mescaline : la religion du peyotl." Annales de Toxicologie Analytique 16, no. 1 (2004): 18–21. http://dx.doi.org/10.1051/ata/2004021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Cassels, Bruce K. "Alkaloids of the Cactaceae — The Classics." Natural Product Communications 14, no. 1 (2019): 1934578X1901400. http://dx.doi.org/10.1177/1934578x1901400123.

Full text

Abstract:

Alkaloids of the Cactaceae have been studied for the last 120 years. The first half of that period provided the “classic” compounds, after which a large number of usually very similar analogs were isolated or determined with modern methods. Although some unusual synthetic approaches have been developed, their preparation is generally quite straightforward. Their biosynthesis has been studied but, particularly in the case of the isoquinoline compounds, important aspects have not been addressed. Due to its striking effects, the pharmacology of mescaline has been studied more intensely than that of the other phenethylamines present in cacti, followed only by hordenine. The many 1,2,3,4-tetrahydroisoquinoline alkaloids have attracted much less interest and have often been considered practically inactive. Nevertheless, some recorded activities of this group of compounds suggests a need for additional studies, especially in connection with their co-administration with mescaline, as in dried cacti and in beverages prepared from them.

APA, Harvard, Vancouver, ISO, and other styles

19

Sessa, Ben. "Can psychedelics have a role in psychiatry once again?" British Journal of Psychiatry 186, no. 6 (2005): 457–58. http://dx.doi.org/10.1192/bjp.186.6.457.

Full text

Abstract:

Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.

APA, Harvard, Vancouver, ISO, and other styles

20

Cassels, Bruce K., and Patricio Sáez-Briones. "Dark Classics in Chemical Neuroscience: Mescaline." ACS Chemical Neuroscience 9, no. 10 (2018): 2448–58. http://dx.doi.org/10.1021/acschemneuro.8b00215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

KEMPLEY, EILÍS. "Julian Trevelyan, Walter Maclay and Eric Guttmann: drawing the boundary between psychiatry and art at the Maudsley Hospital." British Journal for the History of Science 52, no. 4 (2019): 617–43. http://dx.doi.org/10.1017/s0007087419000463.

Full text

Abstract:

AbstractIn 1938, doctors Eric Guttmann and Walter Maclay, two psychiatrists based at the Maudsley Hospital in London, administered the hallucinogenic drug mescaline to a group of artists, asking the participants to record their experiences visually. These artists included the painter Julian Trevelyan, who was associated with the British surrealist movement at this time. Published as ‘Mescaline hallucinations in artists’, the research took place at a crucial time for psychiatry, as the discipline was beginning to edge its way into the scientific arena. Newly established, the Maudsley Hospital received Jewish émigrés from Germany to join its ranks. Sponsored by the Rockefeller Foundation, this group of psychiatrists brought with them an enthusiasm for psychoactive drugs and visual media in the scientific study of psychopathological states. In this case, Guttmann and Maclay enlisted the help of surrealist artists, who were harnessing hallucinogens for their own revolutionary aims. Looking behind the images, particularly how they were produced and their legacy today, tells a story of how these groups cooperated, and how their overlapping ecologies of knowledge and experience coincided in these remarkable inscriptions.

APA, Harvard, Vancouver, ISO, and other styles

22

Haghdadi, Mina, and Mohammad Fatemi. "Artificial neural network prediction of the psychometric activities of phenylalkylamines using DFT-calculated molecular descriptors." Journal of the Serbian Chemical Society 75, no. 10 (2010): 1391–404. http://dx.doi.org/10.2298/jsc100408116h.

Full text

Abstract:

In the present work, a quantitative structure-activity relationship (QSAR) method was used to predict the psychometric activity values (as mescaline unit, log MU) of 48 phenylalkylamine derivatives from their density functional theory (DFT) calculated molecular descriptors and an artificial neural network (ANN). In the first step, the molecular descriptors were obtained by DFT calculation at the 6-311G

APA, Harvard, Vancouver, ISO, and other styles

23

Colace, Claudio. "Drug Dreams in Mescaline and LSD Addiction." American Journal on Addictions 19, no. 2 (2010): 192. http://dx.doi.org/10.1111/j.1521-0391.2009.00023.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bisson, Frédéric. "Le swing cosmique. Whitehead à la mescaline." chromatikon 5 (2009): 133–50. http://dx.doi.org/10.5840/chromatikon2009511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Gurschler, Ivo. "The fourfold discovery of Mescaline (1896–1919)." Monatshefte für Chemie - Chemical Monthly 150, no. 5 (2019): 941–47. http://dx.doi.org/10.1007/s00706-019-02444-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Oepen, G., M. Fuenfgeld, A. Harrington, L. Hermle, and H. Botsch. "Right hemisphere involvement in mescaline-induced psychosis." Psychiatry Research 29, no. 3 (1989): 335–36. http://dx.doi.org/10.1016/0165-1781(89)90081-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Smith, Thomas. "On Sartre and the Drug Connection: A Response to Haynes-Curtis." Philosophy 70, no. 274 (1995): 590–93. http://dx.doi.org/10.1017/s0031819100065840.

Full text

Abstract:

In Sartre and the Drug Connection, Carole Haynes-Curtis claims that previous commentators on the philosopher's writings have failed to recognize the significance of the impact of a mescalin experiment on Sartre's early philosophical perspective. ‘The residual effects of this nightmarish experience’, Haynes-Curtis claims, ‘haunted him for many years to come’, and was essentially the result of Sartre undergoing what, in modern parlance, is sometimes called a ‘Bad Trip’. (SDC 87)

APA, Harvard, Vancouver, ISO, and other styles

28

Krebs, Teri S., and Pål-Ørjan Johansen. "Over 30 million psychedelic users in the United States." F1000Research 2 (March 28, 2013): 98. http://dx.doi.org/10.12688/f1000research.2-98.v1.

Full text

Abstract:

We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. There were approximately 32 million lifetime psychedelic users in the US in 2010; including 17% of people aged 21 to 64 years (22% of males and 12% of females). Rate of lifetime psychedelic use was greatest among people aged 30 to 34 (total 20%, including 26% of males and 15% of females).

APA, Harvard, Vancouver, ISO, and other styles

29

Rose-Munch, Françoise, René Chavignon, Jean-Philippe Tranchier, Vanessa Gagliardini та Eric Rose. "Mescaline synthesis via tricarbonyl (η6-1,2,3-trimethoxybenzene)chromium complex". Inorganica Chimica Acta 300-302 (квітень 2000): 693–97. http://dx.doi.org/10.1016/s0020-1693(00)00011-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Friedhoff, A. J., and M. Goldstein. "NEW DEVELOPMENTS IN METABOLISM OF MESCALINE AND RELATED AMINES *." Annals of the New York Academy of Sciences 96, no. 1 (2006): 5–13. http://dx.doi.org/10.1111/j.1749-6632.1962.tb50097.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Henry, J. L., J. Epley, and T. P. Rohrig. "The Analysis and Distribution of Mescaline in Postmortem Tissues." Journal of Analytical Toxicology 27, no. 6 (2003): 381–82. http://dx.doi.org/10.1093/jat/27.6.381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Yamamoto, Tsuneyuki, Masuo Ohno, Shin-ichi Yatsugi, Yasuhiro Fujikawa, and Showa Ueki. "Nootropic Candidates Inhibit Head-Twitches Induced by Mescaline in Mice." Japanese Journal of Pharmacology 59, no. 3 (1992): 419–21. http://dx.doi.org/10.1016/s0021-5198(19)35545-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Casado, Raquel, Iñigo Uriarte, Rita Yolanda Cavero, and Maria Isabel Calvo. "LC-PAD Determination of Mescaline in Cactus “Peyote” (Lophophora williamsii)." Chromatographia 67, no. 7-8 (2008): 665–67. http://dx.doi.org/10.1365/s10337-008-0553-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Clark, Peder. "Mike Jay, Mescaline: A Global History of the First Psychedelic." Social History of Medicine 33, no. 3 (2020): 1032–33. http://dx.doi.org/10.1093/shm/hkz130.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Gennaro, M. C., E. Gioannini, D. Giacosa, and D. Siccardi. "Determination of Mescaline in Hallucinogenic Cactaceae by Ion-Interaction HPLC." Analytical Letters 29, no. 13 (1996): 2399–409. http://dx.doi.org/10.1080/00032719608002260.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

MONTE, A. P., S. R. WALDMAN, D. MARONA-LEWICKA, et al. "ChemInform Abstract: Dihydrobenzofuran Analogues of Hallucinogens. Part 4. Mescaline Derivatives." ChemInform 29, no. 1 (2010): no. http://dx.doi.org/10.1002/chin.199801111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Yamamoto, Tsuneyuki, Masuo Ohno, Shin-ichi Yatsugi, Yasuhiro Fujikawa, and Showa Ueki. "Nootropic Candidates Inhibit Head-Twitches Induced by Mescaline in Mice." Japanese Journal of Pharmacology 59, no. 3 (1992): 419–21. http://dx.doi.org/10.1254/jjp.59.419.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Betancourt, Michael. "A Taxonomy of Abstract Form Using Studies of Synesthesia and Hallucinations." Leonardo 40, no. 1 (2007): 59–65. http://dx.doi.org/10.1162/leon.2007.40.1.59.

Full text

Abstract:

The author proposes a taxonomy of abstract form anchored in an examination of the history and theory of synesthesia and abstract art. The foundations of this taxonomy lie in empirical psychological studies of “form-constants” found in cross-modal synesthetic visions and hallucinatory states, specifically the work of Heinrich Klüver in his examinations of mescaline and the mechanisms producing visual hallucinations. While the proposed taxonomy is limited only to synesthesia-inspired abstraction, it has suggestive possibilities when considered in relation to other forms of non-synesthetic abstraction such as Islamic Art, the geometric forms found on classical Greek vases, and other kinds of decorative abstract patterns.

APA, Harvard, Vancouver, ISO, and other styles

39

Moores, D. J. "Dancing the Wild Divine: Drums, Drugs, and Individuation." Journal of Jungian Scholarly Studies 15, no. 1 (2020): 64–83. http://dx.doi.org/10.29173/jjs126s.

Full text

Abstract:

For complex reasons, Carl Jung was apprehensive of ecstatic rites in which participants dance to hypnotic drumming and transcend normal states of ego. He was also strongly opposed to the use of LSD, mescaline, and other psychotropic agents often used in such rites, cautioning that psychedelics facilitate access to unconscious energies one is ill-equipped to absorb. This paper represents a challenge to Jung's thinking on both issues. Drawing upon recent research in shamanic studies and the once-again blossoming field of psychedelic research, D. J. Moores demonstrates the limitations of Jung's caution and argues for the value of ecstatic rites in depth work.

APA, Harvard, Vancouver, ISO, and other styles

40

Cengisiz, Cengiz, Ufuk Bal, Kemal Ulutas, and Nebile Daglioglu. "Mescaline abuse via peyote cactus: the first case report in Turkey." Anatolian Journal of Psychiatry 17, no. 3 (2016): 68. http://dx.doi.org/10.5455/apd.227565.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Hermle, L., E. Gouzoulis-Mayfrank, and M. Spitzer. "Blood Flow and Cerebral Laterality in the Mescaline Model of Psychosis." Pharmacopsychiatry 31, S 2 (1998): 85–91. http://dx.doi.org/10.1055/s-2007-979352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Lautens, Mark, and Dino Alberico. "Palladium-Catalyzed Alkylation-Alkenylation Reactions: Rapid Access to Tricyclic Mescaline Analogues." Synlett 2006, no. 18 (2006): 2969–72. http://dx.doi.org/10.1055/s-2006-941583.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Sykes, Elizabeth A. "Mescaline-induced motor impairment in rats, assessed by two different methods." Life Sciences 39, no. 12 (1986): 1051–58. http://dx.doi.org/10.1016/0024-3205(86)90196-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Fundarò, Anna, Luigi Molinengo, Maria C. Cassone, and Marco Orsetti. "Action of a chronic administration of mescaline in dynamic behavioural situations." Progress in Neuro-Psychopharmacology and Biological Psychiatry 10, no. 1 (1986): 41–48. http://dx.doi.org/10.1016/0278-5846(86)90042-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Legallois, Dominique. "Linguistique de l’événement mescalinien chez Henri Michaux." Revue Romane / Langue et littérature. International Journal of Romance Languages and Literatures 47, no. 1 (2012): 144–59. http://dx.doi.org/10.1075/rro.47.1.08leg.

Full text

Abstract:

Misérable Miracle by Henri Michaux, is not only a poetic account of mescalinian experiments : in our opinion, the book also gives rise to a semiotic thinking on the notion of event. The paper is devoted to a detailed investigation of the manner in which 1) words — thanks to their iconic property — are events, 2) sentences are formed by the structure of events, and 3) texts — thanks to the rhetoric of energeia and enargeia — are designed as events by the reading horizon.

APA, Harvard, Vancouver, ISO, and other styles

46

Kyzar, Evan J., Christopher Collins, Siddharth Gaikwad, et al. "Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology." Progress in Neuro-Psychopharmacology and Biological Psychiatry 37, no. 1 (2012): 194–202. http://dx.doi.org/10.1016/j.pnpbp.2012.01.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Daly, John, Julius Axelrod, and Bernhard Witkop. "METHYLATION AND DEMETHYLATION IN RELATION TO THE IN VITRO METABOLISM OF MESCALINE." Annals of the New York Academy of Sciences 96, no. 1 (2006): 37–43. http://dx.doi.org/10.1111/j.1749-6632.1962.tb50099.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ahrendt, Kateri A., Robert G. Bergman, and Jonathan A. Ellman. "Synthesis of a Tricyclic Mescaline Analogue by Catalytic C−H Bond Activation." Organic Letters 5, no. 8 (2003): 1301–3. http://dx.doi.org/10.1021/ol034228d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Ghansah, E., P. Kopsombut, M. A. Maleque, and A. Brossi. "Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission." Neuropharmacology 32, no. 2 (1993): 169–74. http://dx.doi.org/10.1016/0028-3908(93)90097-m.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Molinengo, Luigi, Maria Chiara Cassone, Alessandra Baroli, and Marco Orsetti. "Mescaline action on “memory decay” and “problem solving” behavior in the rat." Progress in Neuro-Psychopharmacology and Biological Psychiatry 10, no. 6 (1986): 709–15. http://dx.doi.org/10.1016/0278-5846(86)90055-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!